Press Releases

DZIF scientists Prof. Rolf Hilgenfeld of the University of Lübeck and Dr. Albrecht von Brunn of the Ludwig-Maximilians University of Munich  discovered how SARS viruses enhance the production of viral

What exactly happens when the corona virus SARS-CoV-2 infects a cell? In an article published in Nature, a team from the Technical University of Munich (TUM) and the Max Planck Institute of

Influenza vaccines need to be evaluated every year to ensure they remain effective against new influenza viruses. Will the same apply to COVID-19 vaccines? In order to gauge whether and to what extent

The discovery of a previously unknown hepatitis B virus in donkeys and zebras opens up new opportunities for understanding the course of the disease. A global research consortium was able to show that

The treatment of tuberculosis (TB) is long, demanding, and expensive. In particular, the ever increasing emergence of resistant tuberculosis bacteria requires a lot of patience: In these cases, the

Hepatitis E is an infectious disease of the liver found across the globe. It is caused by the hepatitis E virus and in most cases heals by itself. However, in patients with a suppressed immune system

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as

Patients have a high risk of serious infections after organ or stem cell transplantation. The number of these complications is large, but too little is currently known about the links between

Staphylococcus aureus (S. aureus) ranks among the globally most important causes of infections in humans and is considered a dreaded hospital pathogen. Active and passive immunisation against multi

The search for effective antiviral agents against the new coronavirus is in full swing. Using a novel approach, Tübingen bioinformaticians have now discovered a weakness in the virus that could be